Coverage featuring Dr. Maher Mahmoud in Egyptian media — expert commentary on skin, hair and sun protection. Each piece links to its original publisher.
26 articles
Distinguishes between acute urticaria (lasting under 6 weeks, affecting 1 in 5 people, triggered by foods, latex, NSAIDs, insect stings, or stress) and chronic autoimmune urticaria linked to thyroid or liver conditions.
Discusses the FDA approval of Opzelura (ruxolitinib) cream for non-segmental vitiligo in patients aged 12 and older, explaining how JAK inhibitors restore pigment.
Explains how toenail fungal infection thickens and discolors nails and can spread between toes ("athlete's foot"), warning against walking barefoot in pools/gyms, sharing nail clippers, or wearing artificial nails.
Explains how biological therapy targets specific immune pathways in moderate-to-severe psoriasis and outlines pre-treatment screening requirements.
Original Al-Ahram Gate investigation featuring Dr. Maher Mahmoud on biological treatments for resistant psoriasis and psoriatic arthritis.
Reassures readers that bright red sesame-seed-sized skin spots are benign cherry angiomas (`الورم الوعائي الكرزي`) caused by dilated capillaries after age 30 rather than skin cancer, and can be removed cosmetically via laser, electrocautery, or cryotherapy.
Sada El-Balad coverage features Dr. Maher Mahmoud discussing considerations for people with vitiligo, including stress, skin injuries, heat and chemical exposure.
Discusses promising gene therapy research using modified HSP70i protein to halt autoimmune destruction of pigment cells and restore natural skin color in vitiligo.
